Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X


press

Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards

Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more


press
New Publication Highlights the Power of the Mission Bio Tapestri Platform to Monitor Therapy Response and Measure Potential Cancer Relapse
press
Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics
press
Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research
press
Mission Bio Tapestri Platform Identifies Novel Resistance Mechanisms with IDH Inhibitor TIBSOVO in Acute Myeloid Leukemias in Agios-led Study
REQUEST QUOTE